Skip to content

Inhibrx Biosciences, Inc. INBX Professional Service Fees Payable

Professional Service Fees Payable at other companies

Nuvation Bio logo
Nuvation BioNUVB
$17.23M+6.1%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue--100%
Operating income-$30.9M+27.9%
Net income-$33.4M+22.8%
EPS (diluted)-$2.15+23.2%

Balance sheet

See full
Cash & equivalents$161.7M-25.3%
Total debt$180.9M+69.8%
Total equity-$21.0M-122%
Total assets$184.0M-24.2%

Cash flow

See full
Operating cash flow-$38.0M-5.9%
CapEx--100%
Free cash flow-$38.0M-5.9%

Valuation

See full
Market cap$1.4B+385%
Enterprise value$1.42B+982%
P/S1,073.7×-280×

Profitability

See full
Operating margin-10,386.5%-5,025pp
Net margin-10,773.5%-878,492pp
FCF margin-9,986.5%-4,727pp

Returns & leverage

See full
Return on equity-197.8%-2,158pp
Debt / equity13.4×+13.3×
Current ratio6.5×+1.3×

Where this comes from

Reported directly by Inhibrx Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccruedProfessionalFeesCurrent.

The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inhibrx Biosciences, Inc.'s professional service fees payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inhibrx Biosciences, Inc.'s professional service fees payable?
Inhibrx Biosciences, Inc. (INBX) reported professional service fees payable of $591K in Q1 2026.
How has Inhibrx Biosciences, Inc.'s professional service fees payable changed year-over-year?
Inhibrx Biosciences, Inc.'s professional service fees payable decreased by 3.7% year-over-year, from $614K to $591K.
What is the long-term trend for Inhibrx Biosciences, Inc.'s professional service fees payable?
Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s professional service fees payable has grown at a -24.3% compound annual growth rate (CAGR), from $780K to $447K.